By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Biventricular pacemakers, implanted cardioverter defibrillators (ICDs), pacemakers, and cardiac loop recorders are just a few of the cardiac implantable electronic devices that can be used to monitor or manage irregular heartbeats in patients with specific heart rhythm abnormalities and heart failure.
A device used to manage, diagnose, track, or treat disease, injury, or other disorders that affect the arteries and veins or the heart itself is known as a vascular medical device. The cardiovascular, peripheral vascular, and neurovascular architecture are all included in this vasculature.
Some types of medical devices include: single use devices (i.e. syringes, catheters) implantable (i.e. hip prosthesis, pacemakers) imaging (i.e. ultrasound and CT scanners).
Medical devices are regarded as a basic part of health systems; the advantages they may offer keep growing since they’re necessary for the safe and effective prevention, diagnosis, treatment, and rehabilitation of illnesses and diseases.
The Nigeria Cardiovascular Medical Devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
GE HealthCare launches new technology that cuts MRI heart scans by up to 83%.The long test periods frequently associated with cardiac MRIs may be decreased since the technique may scan up to 12 times more quickly than existing methods.
Although cardiovascular MRI is the gold standard for assessing heart function, its global acceptance is still relatively modest due to current acquisition speed restrictions. Patients now have to hold their breath for a long period of time since an MRI machine needs many heartbeats to collect all of the necessary imagery.
With the introduction of its new technology, GE HealthCare claims to be tackling the lengthy nature of cardiac MRI scans and picture quality difficulties.
Sonic DL, which has been approved by the US Food and Drug Administration (FDA), synchronizes imaging time with physiological time, enabling it to take pictures in less than a heartbeat.
This not only speeds up the imaging procedure but also makes imaging scans more successful for individuals who have trouble holding their breath, which is a side effect of several cardiac diseases.
According to GE HealthCare, the technology can cut scan times by as much as 83%.The announcement follows the FDA’s recent approval of Precision DL, a deep learning program me from GE HealthCare that improves picture quality in PET/CT scans.
